BioSpace News Archive

Business

Centinel Spine® Announces Record Worldwide prodisc® Total Disc Replacement Revenue and EBITDA-Positive Second Quarter 2023

Centinel Spine®, LLC announced record second quarter 2023 financial results in both revenue growth and profitability.

August 1, 2023
·
6 min read
Biotech Beach

AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test

AXIM Biotechnologies, Inc announced today the receipt of notification by the United States Patent & Trademark Office of several patent allowances.

August 1, 2023
·
8 min read
Pharm Country

Cyduct Diagnostics Recognizes a Visionary Leader in Breast Health: Dr. Susan Love

CYduct Diagnostics an emerging force in women’s breast health would like to recognize the immeasurable impact that Dr. Susan Love, a visionary leader in defining solutions for breast disease had on our company.

August 1, 2023
·
6 min read
Business

Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resources Officer

Catalent, Inc. today announced that Lisa Evoli has been named Senior Vice President & Chief Human Resources Officer, effective immediately.

August 1, 2023
·
2 min read
Business

CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023

CytomX Therapeutics, Inc. today announced that it will report second quarter financial results on Tuesday, August 8, 2023, after the close of U.S. markets.

August 1, 2023
·
2 min read
Genetown

APNIMED to Participate in the 43rd Annual Canaccord Genuity Global Growth Conference

Apnimed, Inc. announced today the company will be participating in the upcoming 43rd Annual Canaccord Genuity Global Growth Conference at the InterContinental in Boston, Massachusetts on Wednesday, August 9, 2023.

August 1, 2023
·
3 min read
Drug Development

Recce Pharmaceuticals Completes First Cohort Dosing of Phase l/ll UTI Rapid Infusion Clinical Trial at Scientia Clinical Research

Recce Pharmaceuticals Ltd is pleased to report the dosing of both male and female subjects in the first cohort of a Phase l/ll urinary tract infection (UTI) clinical trial evaluating R327 at faster infusion rates has been completed at Scientia Clinical Research.

August 1, 2023
·
2 min read
Genetown

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

scPharmaceuticals Inc. today announced that the Company has received positive Type C meeting feedback from the US Food and Drug Administration (FDA) regarding the potential expansion of the FUROSCIX®.

August 1, 2023
·
6 min read
Policy

Actuate Therapeutics Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Pancreatic Cancer

Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for elraglusib for treatment of patients with pancreatic cancer.

August 1, 2023
·
2 min read
Pharm Country

STRATA Skin Sciences to Participate in Upcoming August 2023 Conferences

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the company will be participating in several conferences during August.

August 1, 2023
·
3 min read